ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Comorbidity"

  • Abstract Number: 0481 • ACR Convergence 2024

    Differential Effect of Comorbidities on the Clinical Evolution of Early Arthritis by Sex

    Marina Dueñas1, Juan Carlos Sáez1, María Paula Álvarez2, Patricia Quiroga1, Maryia Nikitsina3, Rosario García-Vicuña2, Ana Ortiz4, Isidoro González-Álvaro3 and Irene Llorente-Cubas4, 1Servicio de Reumatología Hospital La Princesa, Madrid, Madrid, Spain, 2Hospital Universitario de La Princesa, Madrid, Madrid, Spain, 3University Hospital La Princesa, Madrid, Madrid, Spain, 4Hospital Universitario de La Princesa, Madrid, Spain

    Background/Purpose: The prevalence of comorbidities is increased in patients with rheumatoid arthritis (RA) compared to the general population1, but their impact in the earlier stages…
  • Abstract Number: 1340 • ACR Convergence 2024

    Characteristics and Long-term Outcomes of Patients with Rheumatoid Arthritis and Concurrent Calcium Pyrophosphate Deposition Disease

    Natalie Schanzer1, Ted Mikuls2, Bryant England2, Katherine Wysham3, Jorge Rojas4, Sauer brian5, Beth Wallace6, Rachel Elam7, Andreas Reimold8, Gail Kerr9, John Richards10, Gary Kunkel11, Iris Lee12, Isaac Smith13, Paul Monach14, grant Cannon15 and Joshua Baker16, 1Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA, 2University of Nebraska Medical Center, Omaha, NE, 3VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA, 4Seattle VA, Mexico, Mexico, 5Salt Lake City VA/University of Utah, Salt Lake City, UT, 6Michigan Medicine, VA Ann Arbor Healthcare System, Ann Arbor, MI, 7Augusta University, Evans, GA, 8Dallas VA Medical Center, Dallas, TX, 9Washington DC VAMC/Georgetown and Howard Universities, Washington, DC, 10Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, 11University of Utah and George E Wahlen VAMC, Salt Lake City, UT, 12Washington University in St Louis, Saint Louis, MO, 13Duke University Hospital, Durham, NC, 14VA Boston Healthcare System, Boston, MA, 15University of Utah and Salt Lake City VA, Salt Lake City, UT, 16University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Calcium pyrophosphate deposition disease (CPPD) is a common crystalline arthritis that can both present alongside rheumatoid arthritis (RA) and, given its similar pattern of…
  • Abstract Number: 2612 • ACR Convergence 2024

    Two-Week Methotrexate Discontinuation in Autoimmune Rheumatic Diseases Patients Vaccinated with Recombinant Herpes Zoster Vaccine: An Interim Analysis of a Prospective Randomized Phase 4 Study

    Ana Cristina Medeiros-Ribeiro1, Joao de Oliveira2, Nadia Aikawa3, Sandra Pasoto2, Leonard Kupa2, Carla Goncalves Schahin Saad4, Luciana Parente2, ANA PAULA ASSAD2, Eduardo Borba2, Emily Figueiredo Neves Yuki2, Andrea Shimabuco4, Karina Bonfiglioli2, Diogo Domiciano2, Percival Sampaio-Barros4, Andre Franco2, Julio Moraes5, Murillo Dorio2, Claudia Goldenstein-Schainberg2, Henrique Carriço Da Silva2, Lucas Guimarães2, Fernanda Chaer6, Caio Laguna Reis de Carvalho2, Henrique Dalmolin2, Clovis Silva7 and Eloisa Bonfa2, 1Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Jose Dos Campos, Brazil, 2Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, São Paulo, SP, Brazil, 3Rheumatology Division and Pediatric Rheumatology Unit, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil, 4Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, SP, Brazil, 5Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, Jundiai, Brazil, 6Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Santos, Brazil, 7Rheumatology Division and Pediatric Rheumatology Unit, Instituto da Criança e do Adolescente, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, SP, Brazil

    Background/Purpose: Temporary methotrexate (MTX) discontinuation may enhance vaccine immune response, but there are no data for the recombinant zoster vaccine (RZV). This study assessed if…
  • Abstract Number: 0718 • ACR Convergence 2024

    Incidence and Patient Profile Changes in ANCA-Associated Vasculitis Following the SARS-CoV-2 Pandemic

    Laura Ramos Ortiz de Zarate1, Aresio Plaza Lopez2, Alejandro mARTINEZ rODADO3, Maria Machattou1, Pablo Navarro Palomo4, maria alonso de francisco3, Carlota Navarro Joven3, Natalia de la Torre-Rubio4, Olga Rusinovich5, Carolina Merino6, Blanca García Magallón7, Jose Campos Esteban7, hildegarda Godoy Tundidor8, Mónica Fernández Castro9, JESUS SANZ SANZ4, Carmen Barbadillo Mateos7, Carlos Maria Isasi Zaragoza7, Andrea Liso Andrino7, Maria Concepcion Sanchez Fernandez3 and Jose Luis Andreu4, 1Hospital Universitario Puerta de Hierro Majadahonda., Madrid, Spain, 2Hospital Puerta de Hierro Majadahonda, Madrid, Spain, 3Hospital Universitario Puerta de Hierro Majadahonda., Majadahonda, Madrid, Spain, 4Hospital Universitario Puerta de Hierro Majadahonda., Majadahonda, Spain, 5Hospital Universitario Puerta de Hierro Majadahonda., Boadilla del Monte, Spain, 6Hospital Universitario Puerta de Hierro Majadahonda., Majadahonda (Madrid), Spain, 7Servicio de Reumatología, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA , Madrid, Majadahonda, Madrid, Spain, 8Servicio de Reumatología, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA , Madrid, Madrid, Spain, 9Hospital Universitario Puerta de Hierro Majadahonda., Madrid, Madrid, Spain

    Background/Purpose: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis is often linked to previous viral infections. Clinical evidence suggests SARS-CoV-2 virus may follow a similar pattern, with an…
  • Abstract Number: 1347 • ACR Convergence 2024

    Interest of DAS28-γGT in Assessing Cardiovascular Risk Activity in Rheumatoid Arthritis in Routine Practice

    Manon Lesturgie-Talarek1, Fabien Picard2, sabrina hamroun3, Malika Saadi2, Camille Macher4, Aude Deloumeau3, Karim Wahbi2, jacques Blacher4, Yannick Allanore5 and Jérôme Avouac6, 1Université de Paris, Institut Cochin, INSERM U1016 CNRS UMR8104, Paris, France, 2Cardiology Department - Cochin Hospital, Paris, France, 3Rheumatology Department - Cochin Hospital, Paris, France, 4Cardiology Department, Hôtel Dieu Hospital, Paris, France, 5Université Paris Cité, Paris, France, 6Rheumatology A Department, Hôpital Cochin, AP-HP Centre - Université Paris Cité, Paris, France

    Background/Purpose: Rheumatoid arthritis (RA) patients have an increased risk of cardiovascular (CV) mortality, linked to systemic inflammation and the presence of associated CV risk factors.…
  • Abstract Number: 0735 • ACR Convergence 2024

    ANCA-associated Vasculitis (AAV) and Long-term Risk of Cardiovascular Disease: Large-scale Propensity-matched Global Retrospective Cohort Study

    Sebastian Klapa1, Henry Nording2, Marlene Ludwig3, Sabrina Arnold4, Khalaf Kridin5, Anja Staehle6, Ralf Ludwig7 and Peter Lamprecht4, 1University of Lübeck, Department of Rheumatology and Clinical Immunology, Lübeck, 2University of Lübeck, Cardioimmunology Research Group, Lübeck, Germany, 3Independent Researcher, Groß Grönau, Germany, 4University of Lübeck, Department of Rheumatology and Clinical Immunology, Lübeck, Germany, 55. Bar-Ilan University, Azrieli Faculty of Medicine, Safed, Israel, 6University of Lübeck, Department of Rheumatology and Immunology, Lübeck, Germany, 7University of Lübeck, Lübeck Institute of Experimental Dermatology, Lübeck, Germany

    Background/Purpose: In spite of significantly improved therapy during the last years, long-term morbidity and mortality has remained high in ANCA-associated vasculitis (AAV). The main causes…
  • Abstract Number: 1434 • ACR Convergence 2024

    Prevalence of Liver Steatosis in Axial Spondyloarthritis : A Retrospective Study Using Computed Tomography Liver Minus Spleen Attenuation Ratio

    Léa Da silva1, olivier Fakih1, mickael chouk1, delphine weil-verhoeven2, DANIEL WENDLING3, CLEMENT PRATI4 and FRANK VERHOEVEN1, 1Service de rhumatologie, CHU de Besancon, Besançon, France, 2Service d'hépatologie, CHU de Besancon, Besançon, France, 3University Hospital, Besançon, France, 4Service de Rhumatologie, centre hospitalier régional universitaire Jean-Minjoz, Université de Franche-Comté, Besançon, France

    Background/Purpose: The management of axial spondyloarthritis (axSpA) comorbidities includes the metabolic syndrome (2). The latter includes steatotic liver disease (SLD) (3), which is present in…
  • Abstract Number: 0755 • ACR Convergence 2024

    Characteristics Associated with Long-Term Glucocorticoids Use in Patients with New Onset Polymyalgia Rheumatica

    Anisha Dua1, Andrea Rubbert-Roth2, Kerri Ford3, Stefano Fiore4, Lita Araujo3, Timothy Beukelman5, Fenglong Xie6 and Jeffrey Curtis7, 1Northwestern University Division of Rheumatology, Chicago, IL, 2Cantonal Hospital St Gallen, St Gallen, Switzerland, 3Sanofi, Cambridge, MA, 4Sanofi, Bridgewater, NJ, 5Foundation for Advancing Science, Technology, Education and Research, Birmingham, AL, 6University of Alabama at Birmingham, Birmingham, AL, 7The University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Polymyalgia rheumatica (PMR), a common inflammatory rheumatic condition in people aged ≥50 years, is primarily treated with glucocorticoids (GC). Extended GC therapy can increase…
  • Abstract Number: 1602 • ACR Convergence 2024

    Complications in Eosinophilic Granulomatosis with Polyangiitis (EGPA) Patients: A Nationwide Analysis

    Faria Sami1, Ahmad Basharat2, Shahzad Ahmed Sami3 and Saman Tanveer4, 1University of Alabama, Chicago, IL, 2Marshfield Clinic Health System, Marshfeild, WI, 3Trinity Health Oakland Hospital, Pontiac, 4John H. Stroger Jr. Hospital of Cook County, Chicago, IL

    Background/Purpose: Eosinophilic Granulomatosis with Polyangiitis (EGPA) is a rare autoimmune vasculitis of small to medium blood vessels, often causing multisystemic complications leading to increased morbidity and…
  • Abstract Number: 0864 • ACR Convergence 2024

    Obesity Subtypes and Trajectories of Functional Change After 7-years of Follow-up: The Multicenter Osteoarthritis (MOST) Study

    Kristine Godziuk1, Sarah Tilley2, mike LaValley3, Michael Nevitt4, C.E. Lewis5, James Torner6 and Tuhina Neogi2, 1University of Alberta, Edmonton, AB, Canada, 2Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 3Boston University School of Public Health, Arlington, MA, 4UCSF, Orinda, CA, 5University of Alabama at Birmingham, Birmingham, AL, 6University of Iowa, Iowa City

    Background/Purpose: People with knee osteoarthritis (OA) and obesity (i.e. BMI ≥30kg/m2) have poorer function than those without obesity. However, function is not uniform among people…
  • Abstract Number: 1909 • ACR Convergence 2024

    Racial Disparities in Ocular Complications of Systemic Rheumatic Diseases: A Retrospective Cross-Sectional Study

    Insa Mannstadt1, Yiyuan Wu2 and Bella Mehta3, 1Columbia University VP&S, New York, NY, 2Weill Cornell Medicine, New York, NY, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: While systemic rheumatic diseases, including Sjogren's syndrome, systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and spondyloarthropathies, are known to have severe ophthalmologic manifestations, there…
  • Abstract Number: 0975 • ACR Convergence 2024

    Prevalence and Management of Patients with Comorbidities and Frailty in New Onset Polymyalgia Rheumatica

    Sebastian E. Sattui1, FRANK HARTMUT DR. BUTTGEREIT2, Merav Lidar3, Kerri Ford4, Stefano Fiore5, Lita Araujo4, Timothy Beukelman6, Fenglong Xie7 and Jeffrey Curtis8, 1University of Pittsburgh, Pittsburgh, PA, 2Charité University Medicine Berlin, Berlin, Germany, 3Rheumatology Unit, Sheba Medical Center, Tel Hashomer, Israel, 4Sanofi, Cambridge, MA, 5Sanofi, Bridgewater, NJ, 6Foundation for Advancing Science, Technology, Education and Research, Birmingham, AL, 7University of Alabama at Birmingham, Birmingham, AL, 8The University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: PMR, a common inflammatory rheumatic disease in older adults, is primarily treated with glucocorticoids (GC). A high comorbidity burden in PMR may increase the…
  • Abstract Number: 1912 • ACR Convergence 2024

    Greater Glucocorticoid and Less Biologic/Targeted Therapy Use in Midwest PsA Patients Despite Prevalent Comorbidity

    Brittany Banbury1, Sharon Dowell2, Christopher Jenkins3, Emily Holladay4, Cassie Clinton5, Fenglong Xie5, Jingyi Zhang5, Grace Wright6, Jeffrey Curtis7 and Gail Kerr8, 1Mount Sinai Beth Israel, Brooklyn, NY, 2NEA Baptist Memorial Hospital, JONESBORO, AR, 3Medstar Georgetown University Hospital, Washington, DC, 4University of Alabama at Birmingham, Edmond, OK, 5University of Alabama at Birmingham, Birmingham, AL, 6Grace C Wright MD PC, New York, NY, 7University of Alabama at Birmingham, Hoover, AL, 8Washington DC VAMC/Georgetown and Howard Universities, Washington, DC

    Background/Purpose: There is regional variation in the clinical characteristics, treatment, and outcomes of patients with inflammatory arthritis in the US. Despite a higher reported prevalence of…
  • Abstract Number: 1004 • ACR Convergence 2024

    Predictors of Post-acute Sequelae of COVID-19 in Patients with Rheumatoid Arthritis: A Retrospective Analysis of a Large Health System in the Midwestern United States

    Ernesto Lopez Castillo1 and Jeffrey Ording2, 1University of Colorado, Denver, CO, 2Advocate Illinois Masonic Medical Center, Chicago, IL

    Background/Purpose: Evidence suggests that patients with autoimmune diseases or immunosuppressive conditions have a higher risk of poor outcomes related to Coronavirus disease 2019 (COVID-19) infection.…
  • Abstract Number: 1986 • ACR Convergence 2024

    Disease Flare Following Immune Checkpoint Inhibition in Patients with Cancer and Preexisting Vasculitis

    Juan Sevillano1, Yixuan Zhou2, Juan Ruiz3, Noha Abdel-Wahab4 and Maria Suarez-Almazor1, 1MD Anderson Cancer Center, Houston, TX, 2Baylor College of Medicine, Houston, 3MD Anderson, Houston, TX, 4University of Texas MD Anderson Cancer Center, houston, TX

    Background/Purpose: Immune checkpoint inhibitors (ICI) are effective therapies for patients with cancer, but they often cause immune-related adverse events (irAE). There is limited data on…
  • 1
  • 2
  • 3
  • …
  • 19
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology